William Richard White - 12 Dec 2023 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Role
Director
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
Issuer symbol
IRON
Transactions as of
12 Dec 2023
Net transactions value
-$1,914,356
Form type
4
Filing time
14 Dec 2023, 16:15:12 UTC
Previous filing
12 Dec 2023
Next filing
18 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRON Common Stock Options Exercise $55,873 +21,084 $2.65* 21,084 12 Dec 2023 Direct
transaction IRON Common Stock Options Exercise $53,510 +5,427 +26% $9.86 26,511 12 Dec 2023 Direct
transaction IRON Common Stock Options Exercise $94,500 +7,000 +26% $13.50 33,511 12 Dec 2023 Direct
transaction IRON Common Stock Sale $719,214 -12,100 -36% $59.44 21,411 12 Dec 2023 Direct F1
transaction IRON Common Stock Sale $69,532 -1,091 -5.1% $63.73 20,320 12 Dec 2023 Direct F2
transaction IRON Common Stock Sale $1,061,341 -16,263 -80% $65.26 4,057 12 Dec 2023 Direct F3
transaction IRON Common Stock Sale $268,151 -4,057 -100% $66.10 0 12 Dec 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRON Stock Option (Right to Buy) Options Exercise $0 -21,084 -75% $0.000000 7,024 12 Dec 2023 Common Stock 21,084 $2.65 Direct F5
transaction IRON Stock Option (Right to Buy) Options Exercise $0 -5,427 -56% $0.000000 4,216 12 Dec 2023 Common Stock 5,427 $9.86 Direct F6
transaction IRON Stock Option (Right to Buy) Options Exercise $0 -7,000 -100% $0.000000* 0 12 Dec 2023 Common Stock 7,000 $13.50 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.6974, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.51 to $63.883, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.995, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.3684, inclusive.
F5 The shares underlying this option vest in 16 equal quarterly installments following November 27, 2020, subject to the Reporting Person's continued service on each such vesting date.
F6 The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.
F7 The shares underlying this option are fully vested and exercisable as of the date hereof.